Boosting Flu Shot Uptake: How Email Nudges Encourage Patients with Acute MI to Vaccinate
Pooled Data from NUDGE-FLU Trials Show Effective Messaging for High-Risk Patients
Background
Patients with a history of acute myocardial infarction (MI) face increased cardiovascular risks from influenza infections. A pooled analysis from the NUDGE-FLU trials reveals that email reminders can effectively encourage vaccination among these high-risk patients.
Key Findings
-
Effective Messaging: Messaging that highlights the cardiovascular benefits of flu vaccination significantly helps patients who are hesitant about vaccines. This includes those who did not receive their flu shot the previous year and younger patients with recent MIs.
-
Trial Setup: The NUDGE-FLU trials, situated in Denmark, used the governmental email system to send reminders about influenza vaccinations to study participants.
-
Extent of Problem: Influenza significantly impacts health in the U.S., with the CDC reporting millions of illnesses, hospitalizations, and deaths during the 2023-2024 season. Almost half of hospitalizations involved patients with cardiovascular disease.
- Implementation Opportunities: Many individuals are uncertain about vaccination decisions each flu season. Targeted messaging can effectively influence this uncertain group.
Study Insights
- The combined analysis included data from over 2.1 million participants, with a notable 59,458 having a history of acute MI.
- Vaccination rates were similar for older patients regardless of MI history in the first two trials (84% vs. 82% in NUDGE-FLU; 78% vs. 76% in NUDGE-FLU-2). The younger group (NUDGE-FLU-CHRONIC) showed much lower rates (40% for MI history and 36% without).
- Overall vaccine uptake improved for both groups when nudged. However, a specific letter emphasizing CV benefits led to a better response from acute MI patients, particularly those who were unvaccinated last season.
Conclusions and Recommendations
- The study suggests that simple changes in messaging can significantly improve vaccination rates among high-risk patients.
- Future studies should validate these findings in the U.S., where vaccination acceptance varies greatly.
Expert Opinions
Experts highlight caution in applying these results beyond Denmark due to differences in healthcare systems and vaccination awareness. Current vaccination rates in the U.S. indicate that a coordinated effort is necessary to address misconceptions and encourage flu shot acceptance.
